IntenOxy 5 is a new stationary oxygen concentrator available for to HME/DME companies in the United States.



RT’s Three Key Takeaways

  1. Caire has launched the IntenOxy 5 stationary oxygen concentrator in the US and Puerto Rico, with plans to expand to Canada.
  2. The device delivers up to 95.5% oxygen concentration with flow settings from 0.5 to 5 LPM, weighs 34.2 lbs, and operates efficiently with low power consumption.
  3. Designed for durability and ease of use, the IntenOxy 5 supports home oxygen therapy needs while reducing maintenance and operating costs for providers.


Caire has announced the availability of its new IntenOxy 5 stationary oxygen concentrator, according to a company announcement. The device is available for sale in the United States and Puerto Rico, and will soon be available in Canada, Caire says.

The IntenOxy 5 offers effective oxygen delivery with up to 95.5% concentration and flow settings from 0.5 to 5 LPM, and carries a three-year warranty.

Weighing only 34.2 lbs, the device is sleek and compact, blending into the surroundings and boasting a low power consumption of <350W at the 5 LPM setting, according to Caire.

When combined with Caire’s award-winning FreeStyle Comfort portable oxygen concentrator, the IntenOxy 5 provides yet another solution to help DME and HME customers stock their fleets with what the industry calls non-delivery solutions—equipment that requires minimal maintenance and reduces overall operating expenses.

“The IntenOxy 5 Stationary Oxygen Concentrator has been an excellent addition to our oxygen therapy portfolio. The unit is a key component to how our DME and HME customers serve their respiratory patients, providing them with an at-home device that delivers the oxygen they need as they navigate activities of daily living,” said Ken Hosako, president and CEO of Caire.

With more than 1 million Medicare recipients receiving long-term oxygen therapy (LTOT) at home,1 the device offers durable and home medical equipment providers another solution to meet their respiratory patients’ at-home oxygen therapy needs. More information is available at the company’s website.



Reference

  1. More information can be found online at the National Library of Medicine: https://pmc.ncbi.nlm.nih.gov/articles/PMC2897694/. Stoller, J. K., Panos, R. J., Krachman, S., Doherty, D. E., Make, B., and the Long-term Oxygen Treatment Trial Group. Oxygen Therapy for Patients with COPD: Current Evidence and the Long-Term Oxygen Treatment Trial. Chest, 2010 Jul;138(1):179–187. doi: 10.1378/chest.09-2555